Associated Papers
Genes linked to hearing and vestibular phenotypes in humans and mice: an interspecies systematic review.
Ayoub C et al.
Human Genomics, 2025
41430327 (PubMed )
Supplement: 40246_2025_891_MOESM1_ESM.xlsx › Supplementary_Table_S2.
Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers-an observational study.
Satirer Ö et al.
Rheumatology (oxford, England), 2025
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markers.
Satirer Ö et al.
Rheumatology (oxford, England), 2025
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants.
Feng S et al.
Nature Immunology, 2025
39930093 (PubMed )
Supplement: 41590_2025_2088_MOESM3_ESM.xlsx › Table_1
Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy.
Russwurm M et al.
Scientific Reports, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Miyamoto T et al.
Arthritis & Rheumatology (hoboken, N.j.), 2024
Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation.
Cosson C et al.
The Journal of Experimental Medicine, 2024
1–50 of 139 papers
Select a paper to view details